The number of people with susceptibility test result for rifampicin in Afghanistan
Afghanistan: The number of people with susceptibility test result for rifampicin was 17,443 in 2021. ◆ Volatile
Latest (2021)
17,443
Change on year
up 70.1%
World rank
16th
of 155 countries
All-time high
17,443
in 2021
All-time low
2,889
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Afghanistan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Afghanistan is 17,443, measured in 2021. That is the highest value across all 5 years on record.
That represents a change of up 70.1% on the previous year and up 503.8% over five years.
Afghanistan ranks 16th of 155 countries on this measure, in the top 10%.
The number of people with susceptibility test result for rifampicin in Afghanistan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 2,889 | — |
| 2018 | 10,032 | +247.2% |
| 2019 | 5,443 | -45.7% |
| 2020 | 10,255 | +88.4% |
| 2021 | 17,443 | +70.1% |
Afghanistan compared with similar countries
- Afghanistan's 17,443 is above the median for low income countries, which is 1,934, 9.0× the median. (15 countries reporting)
- Afghanistan's 17,443 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 43.0× the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 6,121 | 2,889 | 10,032 | 3 |
| 2020s | 13,849 | 10,255 | 17,443 | 2 |
Countries ranked near Afghanistan
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 812.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,735 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 19 (2025)
- Population ages 00-04, female, annual growth rate 1.78 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0002 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.75 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0002 units per US$ of GDP (2024)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Afghanistan?
- The number of people with susceptibility test result for rifampicin in Afghanistan was 17,443 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Afghanistan?
- The highest recorded value was 17,443 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Afghanistan?
- The lowest recorded value was 2,889 in 2017.
- How does Afghanistan rank for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 16th out of 155 countries with data for 2021.
- Where does this Afghanistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).